Fluvoxamine and Sertraline in Childhood Autism - Does SSRI Therapy Improve Behaviour and/or Mood?
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if fluvoxamine or sertraline reduce the fequency or
severity of aggressive behaviour, obsessive symptoms, or anxiety in young children with
autism. The within-patient variability in this patient population using standard
neuropsychological instruments will also be determined and a predictor model for SSRI
responsitivity based on baseline neuropsychological testing will be developed.